Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    February 2024
  1. GOPALANI SV, Senkomago V, Rim SH, Saraiya M, et al
    Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019.
    J Natl Cancer Inst. 2024;116:275-282.
    PubMed     Abstract available


    September 2023
  2. BAANDRUP L, Maltesen T, Dehlendorff C, Kjaer SK, et al
    HPV vaccination and anal high-grade precancerous lesions and cancer: a real-world effectiveness study.
    J Natl Cancer Inst. 2023 Sep 18:djad189. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  3. GRADISSIMO A, Clarke MA, Xue X, Castle PE, et al
    A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
    J Natl Cancer Inst. 2023 Jul 19:djad134. doi: 10.1093.
    PubMed     Abstract available


  4. BEFANO B, Campos NG, Egemen D, Herrero R, et al
    Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2023;115:788-795.
    PubMed     Abstract available


    April 2023
  5. CASTLE PE
    Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?
    J Natl Cancer Inst. 2023;115:349-351.
    PubMed    


    January 2023
  6. LANDY R, Haber G, Graubard BI, Campos NG, et al
    Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study.
    J Natl Cancer Inst. 2023 Jan 19:djad009. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  7. KREIMER AR, Cernuschi T, Rees H, Brotherton JML, et al
    Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.
    J Natl Cancer Inst. 2022 Oct 4. pii: 6747964. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  8. HU SY, Kreimer AR, Porras C, Guillen D, et al
    Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2022 May 31. pii: 6596052. doi: 10.1093.
    PubMed     Abstract available


  9. LALONDE CS, Teng Y, Burtness BA, Ferris RL, et al
    The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
    J Natl Cancer Inst. 2022 May 14. pii: 6585900. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  10. HUEPENBECKER SP, Meyer LA
    How Can We Pursue Equity in Cervical Cancer Prevention with Existing HPV Genotype Differences?
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530293. doi: 10.1093.
    PubMed    


  11. MIX J, Saraiya M, Hallowell BD, Befano B, et al
    Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530292. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  12. CORREDOR G, Toro P, Koyuncu C, Lu C, et al
    An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients with HPV-Associated Oropharyngeal Cancer.
    J Natl Cancer Inst. 2021 Nov 29. pii: 6446037. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  13. DEHLENDORFF C, Baandrup L, Kjaer SK
    Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
    J Natl Cancer Inst. 2021;113:869-874.
    PubMed     Abstract available


    June 2021
  14. BURTNESS B, Contessa J
    Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
    J Natl Cancer Inst. 2021;113:652-653.
    PubMed    


  15. DESHMUKH AA, Suk R, Shiels MS, Damgacioglu H, et al
    Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
    J Natl Cancer Inst. 2021;113:792-796.
    PubMed     Abstract available


    April 2021
  16. CAMPOS NG, Chaturvedi AK, Kreimer AR
    Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227604. doi: 10.1093.
    PubMed    


  17. KJAER SK, Dehlendorff C, Belmonte F, Baandrup L, et al
    Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227603. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.